
Insilico Biosystems is a bioinformatics and data sciences consultancy specializing in accelerating research and development for unmet biomedical needs within the biotech and pharma industries. They offer a comprehensive suite of services including Compound Profiling & Safety Assessment, Target/Biomarker ID & Validation, Target/Off-Target Safety Assessment, Disease Profiling & Subtyping, Model Selection & Assay Development, and Big Data Management & Computing. Their team comprises experienced computational biologists, data scientists, AI/ML, and IT professionals with a proven track record across various disease areas and therapeutic modalities. Insilico Biosystems leverages integrated data analysis from individual projects and public sources to enhance signal detection and provide actionable interpretations, ultimately driving more impactful R&D decision-making.

Insilico Biosystems is a bioinformatics and data sciences consultancy specializing in accelerating research and development for unmet biomedical needs within the biotech and pharma industries. They offer a comprehensive suite of services including Compound Profiling & Safety Assessment, Target/Biomarker ID & Validation, Target/Off-Target Safety Assessment, Disease Profiling & Subtyping, Model Selection & Assay Development, and Big Data Management & Computing. Their team comprises experienced computational biologists, data scientists, AI/ML, and IT professionals with a proven track record across various disease areas and therapeutic modalities. Insilico Biosystems leverages integrated data analysis from individual projects and public sources to enhance signal detection and provide actionable interpretations, ultimately driving more impactful R&D decision-making.